41. Giant cell arteritis Clinical trials / Disease details


Clinical trials : 131 Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 125

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-001019-26-NL
(EUCTR)
26/02/202114/07/2020Imaging of inflamed arteries in giant cell arteritis with a PET/CT scan.[18F]fluor-PEG-folate PET/CT imaging in Giant Cell Arteritis. giant cell arteritis;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Product Name: [18F]PEG-Folate
INN or Proposed INN: Fluorine-18
Other descriptive name: FLUORINE-18
University Medical Center Groningen, Department of Rheumatology and Clinical ImmunologyNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
10Phase 2Netherlands
2NCT03285945
(ClinicalTrials.gov)
October 201412/10/2016FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid TreatmentFluorine-18-fluorodeoxyglucose Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment - A Diagnostic Window of Opportunity?Giant Cell ArteritisDrug: PET3;Drug: PET10University of AarhusNULLCompleted50 YearsN/AAll24N/ADenmark